The global medical tubing market size is anticipated to reach USD 19,498.5 million by 2030. The market is expected to expand at a CAGR of 6.0% from 2023 to 2030 The prevalence of respiratory diseases such as asthma, lung cancer,…
MedSitter, a leading virtual patient observation solution received top marks from a KLAS Emerging Solutions Spotlight report released today, which revealed positive customer experiences with MedSitter’s innovative solution. The virtual patient observation market is experiencing significant growth as healthcare organizations look…
CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that Mark V. Anquillare has joined the CPSI Board of Directors as an independent director. On July 28, 2023, upon the recommendation of the Nominating and Corporate Governance Committee, the Board…
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that it has launched an overnight marketed public offering of…
Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of tumor-directed oncolytic immunotherapies, and Incyte (NASDAQ:INCY), a global biopharmaceutical company, today announced a clinical trial collaboration and supply agreement to study RP1, Replimune’s…
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) in combination with carboplatin and paclitaxel, followed by Jemperli as a single agent for the treatment of adult patients with primary advanced or recurrent endometrial cancer…
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it now offers menopause testing through its Labcorp OnDemand digital health platform. Approximately 1.3 million women enter menopause each year. While menopause officially marks the end of a woman’s menstrual cycles,…
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2023. “Baxter’s second-quarter performance reflects ongoing solid demand for our diverse, durable portfolio of medically essential products,” said José (Joe) E. Almeida, chairman, president…
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that Vantive will be the name of the company’s proposed spinoff of its Renal Care and Acute Therapies businesses. Vantive is expected to launch as an independent, publicly traded company…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the pivotal Phase 3 KEYNOTE-756 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met one of its dual primary endpoints of pathological…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from two Phase 3 trials evaluating V116, the company’s investigational 21-valent pneumococcal conjugate vaccine in vaccine-naïve and previously vaccinated individuals. If approved,…
Today, on International Self-Care Day, CVS Pharmacy® is expanding its one+other assortment with the new inclusively designed Universal Tools collection to continue its attention to the unique and individual needs of its diverse consumer base. In January 2023, CVS Pharmacy introduced…